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Iowa City, IowaObjectives This study sought to determine the safety and efﬁcacy of radial access compared with
femoral access for primary percutaneous coronary intervention (PCI) in patients with ST-segment
elevation myocardial infarction (STEMI).
Background Numerous randomized controlled trials, including several new studies, have compared
outcomes of these approaches in the context of primary PCI for STEMI patients with inconclusive
results.
Methods We performed a meta-analysis of randomized controlled trials to compare outcomes in
STEMI patients undergoing radial versus femoral access for primary PCI. Primary outcomes were death
and major bleeding evaluated at the longest available follow-up. Secondary outcomes included access
site bleeding, stroke, and procedure time. Twelve studies (N ¼ 5,055) were included. All trials were
conducted in centers experienced with both approaches.
Results Compared with femoral approach, radial approach was associated with decreased risk of
mortality (2.7% vs. 4.7%; odds ratio [OR]: 0.55, 95% conﬁdence interval [CI]: 0.40 to 0.76; p < 0.001) and
decreased risk of major bleeding (1.4% vs. 2.9%; OR: 0.51, 95% CI: 0.31 to 0.85; p ¼ 0.01). Radial access
was also associated with reduction in relative risk of access site bleeding (2.1% vs. 5.6%; OR: 0.35, 95%
CI: 0.25 to 0.50; p < 0.001). Stroke risk was similar between both approaches (0.5% vs. 0.5%; OR: 1.07,
95% CI: 0.45 to 2.54; p ¼ 0.87). The procedure time was slightly longer in the radial group than in the
femoral group (mean difference: 1.52 min; 95% CI: 0.33 to 2.70, p ¼ 0.01).
Conclusions In STEMI patients undergoing primary PCI, the radial approach is associated with
favorable outcomes and should be the preferred approach for experienced radial operators.
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Abbreviations
and Acronyms
CI = conﬁdence interval(s)
MACE = major cardiovascular
adverse events
MI = myocardial infarction
OR = odds ratio
PCI = percutaneous coronary
intervention
STEMI = ST-segment
elevation myocardial
infarction
TIMI = Thrombolysis In
Myocardial Infarction
TLR = target lesion
revascularization
TVR = target vessel
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815Bleeding is among the most common in-hospital compli-
cations of percutaneous coronary intervention (PCI) and is
independently and strongly associated with long-term adverse
outcomes, including myocardial infarction (MI), stroke, and
death (1–5). Patients with ST-segment elevation myocardial
infarction (STEMI) require an urgent revascularization
strategy as well as aggressive antiplatelet and antithrombotic
pharmacotherapy and thus are particularly susceptible to
bleeding complications. Trials of antithrombotic regimens
designed to decrease bleeding complications during STEMI
treatment have been shown to decrease mortality (6,7).
See page 824
Given that a frequent source of bleeding is the arterial
access site, a radial approach rather than the traditional
femoral approach for primary PCI is an attractive strategy to
further improve outcomes due to the well-documented
reduced risk of bleeding complications (8,9). However,
lower bleeding risk with radial access may be counter-
balanced by higher rates of procedural failure and longer
procedural times, which may be detrimental in STEMI
patients where timely reperfusion is critical.
The current American College of Cardiology Foundation/
American Heart Association STEMI guidelines do not
mention the preferred approach for access site in STEMI
patients (10). A number of nonrandomized studies have
compared radial access with femoral access in patients under-
going primaryPCI for STEMI.However,most of these studies
were observational in nature and thus limited because of the
potential for confounding and selection bias. On the other
hand, ﬁrm conclusions from the randomized controlled trials
available are limited due to a lack of power for the main
outcomes of mortality, bleeding, and stroke. We have per-
formed an updated meta-analysis of randomized clinical
trials comparing the efﬁcacy and safety of radial versus
femoral approaches for primary PCI in STEMI patients
incorporating data from 3 recently published randomized
controlled trials (11–13).
Methods
This meta-analysis was performed in accordance with the
PRISMA (Preferred Reporting Items for Systemic Reviews
and Meta-Analyses) checklist (14). We conducted
a systematic review of the literature for studies published
from 1960 to December 2012 in PubMed, Scopus,
Clinicaltrials.gov, Web of Science, and Cochrane Central
databases. The following search terms were used: “ST-ele-
vation myocardial infarction,” “STEMI,” “Radial,” and
“Radial vs. Femoral.” Our search was limited to articles in
English. A manual search was also performed using the
“related results” section of PubMed and references fromselected papers. We also performed a hand search of
abstracts presented at conferences (through Web of Science,
as well as Transcatheter Cardiovascular Therapeutics,
American College of Cardiology, and American Heart
Association online presentations).
Trial selection. To be selected for inclusion in the meta-
analysis, studies were required to meet the following inclu-
sion criteria: 1) be randomized; 2) have a comparison
between radial and femoral access; 3) have a patient pop-
ulation comprising patients undergoing primary PCI for
STEMI; and 4) have measured at least 1 of the following
outcomes as their endpoint: death; major bleeding; major
cardiovascular adverse events (MACE); access site compli-
cations/bleeding; stroke; MI; target lesion revascularization
(TLR)/target vessel revascularization (TVR); and procedure
time. Studies that did not ﬁt these criteria were excluded
from the analysis (Fig. 1).
Outcomes. The outcomes of
interest were evaluated at the
longest available follow-up. We
used death and major bleeding as
our coprimary outcomes of interest.
For major bleeding, Thrombolysis
In Myocardial Infarction (TIMI)
major bleeding rates were used
where available; in the studies
where this was not possible, the
study deﬁnition of major bleeding
was used (Table 1). Secondary
outcomes analyzed were MACE,
access site bleeding, stroke, MI,
TLR/TVR, and procedure time.
For MACE, individual compo-
nents were noted and included in
the table for study characteristics,
but the outcome values were
taken as presented from the studies despite variations in
deﬁnitions.
Data extraction and quality assessment. Two authors eval-
uated each study for inclusion and extracted data in duplicate
using a standardized protocol and reporting form. Differ-
ences were resolved by consensus. The risk assessment tool
recommended by the Cochrane Collaboration was used to
evaluate the risk of bias in the included studies.
Data synthesis and analysis. Data were extracted on an
intent-to-treat basis. The odds ratio (OR) was used as the
measure of effect in the overall comparison test, and the
Mantel-Haenszel method was used to combine study data.
The heterogeneity of the studies was analyzed using a chi-
square test for which a p value <0.2 was considered
potentially heterogeneous. An I2 test of heterogeneity, which
describes the percentage of total variation across studies that
is due to heterogeneity rather than due to chance, was also
performed for each of the comparisons. Heterogeneity is
revascularization
Figure 1. Flow Diagram of Meta-Analysis Trial Selection
Flowchart showing literature search strategy, and selection process for inclusion in meta-analysis. PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment
elevation myocardial infarction.
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816described as low, moderate, and high, based on I2 values of
25%, 50%, and 75%, respectively. A 2-sided p value <0.05
was considered to be statistically signiﬁcant. We used
a random effects model for all our analyses. Results for
individual trials and summary results are expressed as an OR
with 95% conﬁdence intervals (CI). We also created funnel
plots to visually assess publication bias. All statistical
calculations were performed using Review Manager (Rev-
Man version 5.1, The Nordic Cochrane Centre, The
Cochrane Collaboration, Copenhagen, Denmark).
Results
Of the 678 studies that returned on our literature search, 12
studies met the inclusion criteria (Fig. 1, Table 1) (11–13,
15–23). One study has been presented only as an abstract, but
was included in the analysis (13). The included studies con-
tained a combined total of 5,055 patients, with 2,492 patients
being in the radial arm and 2,563 in the femoral arm. The
mean age was 61 years (range 53 to 71 years) and men
accounted for the majority of subjects (average: 75%, range
64% to 88%) (Table 1). In the majority of the studies, the
arterial access was obtained with a 6-F sheath, however, usage
of 7-F sheath was relatively more common in the femoral
access in 3 studies (11,12,16) (Table 1). Use of glycoprotein
IIb/IIIa receptor inhibitors was common and did not differ
between the study arms in most of the included studies.
Crossover to the other arm was more frequent in the radial
group (4.6%) than in the femoral group (1.1%). Follow-upwas
limited to in-hospital only in 4 studies (17,18,20,23), whereas
it ranged from 1 month to 9 months for the remainder.On evaluating heterogeneity, we found the studies to be
homogeneous for all outcomes (I2 ranging from 0% to 17%,
p > 0.2) except for procedure time, where a potential for
heterogeneity was noted (I2 ¼ 30%, p ¼ 0.18). Funnel plots
for the primary outcomes did not show obvious evidence for
publication bias (Online Figs. 1 to 3). The risk of bias
assessment tool found most of the studies to be low risk with
regard to attrition and reporting bias, but the risk was
unclear regarding selection, performance, and detection bias
in the majority of the studies, mostly due to inadequate
reporting in the manuscripts (Online Figs. 4 and 5).
Primary and secondary outcomes. All studies except Li et al.
(18) reported data on death and major bleeding. There were
62 of 2,308 (2.7%) deaths in the radial group compared with
112 of 2,377 (4.7%) deaths in the femoral group. This analysis
showed a signiﬁcant reduction in mortality with radial access,
with the odds of death being almost one-half that for femoral
arm (OR: 0.55, 95% CI: 0.40 to 0.76; p < 0.001) (Fig. 2).
A similar reduction was seen in the rate of major bleeding:
32 of 2,308 (1.4%) versus 70 of 2,377 (2.9%) (OR: 0.51,
95% CI: 0.31 to 0.85; p < 0.05) (Fig. 3). A separate meta-
analysis was done for our primary outcomes stratiﬁed based on
the single-center versus multicenter trials (Online Figs. 6 and
7). Neither death nor major bleeding was signiﬁcantly
different in the study arms in the single-center trials analysis,
likely because of the low number of patients included. For
the analysis of the data derived from multicenter trials, there
was a signiﬁcantly decreased rate of death with the radial
approach and no signiﬁcant difference in major bleeding.
Nine studies had extractable data for composite MACE.
Rates of MACE were lower in the radial group: 102
Table 1. Individual Characteristics of Included Studies
Study/First Author (Ref. #)
TEMPURA
(15)
RADIAL-AMI
(16)
FARMI
(17)
Li et al.
(18)
Yan et al.
(19)
RADIAMI
(20)
Gan et al.
(21)
Hou et al.
(22)
RADIAMI II
(23)
RIFLE-STEACS
(11)
RIVAL
(12)
STEMI-RADIAL
(13)
Year 2003 2005 2007 2007 2008 2009 2009 2009 2011 2012 2012 2012
Mean age, yrs 67 55 59 56 70.8 59.5 52.95 65.55 59.6 65 59 62
Female, % 17.9 12 15.8 34 25.2 32 19.5 29.5 36 26.7 20.9 33
No. of centers 1 Multiple* 1 1 1 1 2 1 1 4 158 4
Patients, N 149 50 114 370 103 100 195 200 108 1,001 1,958 707
Primary PCI,y %,
TRA/TFA
All 36/32 45.6/56.1 NR All All All All All 91.8/93 87.3/88.8 NA
Gp IIb/IIIa
Inhibitors, %,
TRA/TFA
None 95/92 NR NR All 44/42 31.1/34.3 All 51/54 67.4/69.9 34.5/31.1 45/45
MACE deﬁnition Death
MI
TLR
None None None Death
MI
TVR
Death
MI
Death
MI
CABG
TLR
Death
MI
TVR
Death
MI
CABG
TVR
Death
MI
Stroke
TLR
Death
MI
Stroke
Death
MI
Stroke
Sheath size, 6-
F/7-F
NR TRA: 100%/0%
TFA: 88%/12%
100%/0% NR NR 100%/0% NR NR 100%/0% TRA: 81.4%/18.6%
TFA: 90.8%/9.2%
TRA:
98.6%/1.4%
TFA: 95.5%/4.5%
TRA: 100%/0%
TFA: 99.2%/0.8%
Crossover, %TRA
to TFA, %TFA
to TRA
0%,
1.4%
4%,
0%
12.3%,
1.8%
1.6%,
1.1%
1.8%,
0%
8%,
2%
1.1%,
0%
4%,
0%
4.1%,
1.7%
9.4%,
2.8%
5.3%,
1.6%
3.7%,
0.6%
Bleeding
deﬁnition
used
Study page 27
(15)
Study page 544
(16)
TIMIz None TIMIz Study page 334
(20)
None Study page 159
(22)
Study page 765
(23)
TIMIz TIMIz HORIZONS-AMI
Follow-up
duration
Hospital/9
months
Hospital/30
days
Hospital Hospital 30 days Hospital Hospital/6
months
30 days Hospital 30 days 30 days 30 days
*Exact number not reported in manuscript. yNonprimary PCI were: rescue PCI (RADIAL-AMI, RIFLE-STEACS), rescue PCI þ facilitated PCI (FARMI), and Secondary PCI (i. e., facilitated, rescue, or routine adjunctive) (RIVAL). zTIMI major vascular bleeding. 5-F or 6-F
sheaths.
FARMI ¼ Five French Arterial Access With Reopro in Myocardial Infarction; Gp ¼ glycoprotein; HORIZONS-AMI ¼ Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction; MACE ¼ major adverse cardiac events; MI ¼ myocardial
infarction; NA ¼ not applicable; No. ¼ Numbers; NR ¼ not reported; PCI ¼ percutaneous coronary intervention; RADIAL AMI ¼ Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute
myocardial infarction; RADIAMI ¼ Radial Versus Femoral Approach for Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction; RIFLE-STEACS ¼ Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome;
RIVAL ¼ RadIal Vs femorAL access for coronary intervention trial; STEMI-RADIAL ¼ A Prospective Randomized Trial of Radial vs. Femoral Access in Patients With ST-Segment Elevation Myocardial Infarction; TEMPURA ¼ Test for Myocardial Infarction by Prospective
Unicenter Randomization for Access Sites; TFA ¼ transfemoral approach; TIMI ¼ Thrombolysis In Myocardial Infarction; TLR ¼ target lesion revascularization; TRA ¼ transradial approach; TVR ¼ target vessel revascularization.
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Figure 2. All-Cause Mortality
Meta-analysis of pooled data from randomized studies showing the effect of radial versus femoral access approach on risk of death in STEMI patients treated with
primary PCI. CI ¼ conﬁdence interval; other abbreviations as in Table 1.
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818of 2,226 (4.6%) versus 155 of 2,295 (6.8%) (OR: 0.64, 95%
CI: 0.49 to 0.83; p < 0.001) (Fig. 4). There was a markedly
lower risk of access site bleeding with radial access, with the
odds of such bleeding for the radial group being one-third of
that for the femoral group: 49 of 2,390 (2.1%) versus 139 of
2,466 (5.6%) (OR: 0.35, 95% CI: 0.25 to 0.50) (Fig. 5). Six
studies were included in the analyses for stroke, and no
difference between the 2 groups was found: 10 of 1,927Figure 3. Major Bleeding
Meta-analysis of pooled data from randomized studies showing the effect of radial ve
with primary PCI. Abbreviations as in Table 1 and Figure 2.(0.5%) versus 10 of 1,997 (0.5%) (OR: 1.04, 95% CI: 0.45
to 2.41) (Fig. 6). Similarly, no difference was found between
radial and femoral access on comparing rates of MI (25 of
2,251 [1.1%] vs. 31 of 2,320 [1.3%]; OR: 0.83, 95% CI:
0.49 to 1.41) (Fig. 7) or TLR/TVR (23 of 948 [2.4%] vs. 28
of 958 [2.9%]; OR: 0.79, 95% CI: 0.44 to 1.41) (Fig. 8).
Finally, whereas the procedure time was found to be longer
in the radial access group than in the femoral access group,rsus femoral access approach on risk of major bleeding in STEMI patients treated
Figure 4. MACE
Meta-analysis of pooled data from randomized studies showing the effect of radial versus femoral access approach on risk of MACE in STEMI patients treated with
primary PCI. MACE ¼ major adverse cardiovascular event; other abbreviations as in Table 1 and Figure 2.
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819this difference was small, with the radial access group taking
only 1.5 min longer on average (mean difference: 1.52 min,
95% CI: 0.33 to 2.70; p ¼ 0.01) (Fig. 9).
Discussion
In the present meta-analysis, we found that, compared with
femoral access, radial access was associated with nearly
a 2-fold reduction in the odds of death and a 1.5-fold
reduction in the odds of MACE in STEMI patientsFigure 5. Access Site Bleeding
Meta-analysis of pooled data from randomized studies showing the effect of radial v
treated with primary PCI. Abbreviations as in Table 1 and Figure 2.undergoing primary PCI. Whereas the risk of stroke, MI,
and TLR/TVR were similar between the approaches, major
bleeding and access site bleeding were signiﬁcantly lower
with the radial approach than with the femoral approach.
Importantly, these beneﬁts were observed despite a slight
increase in procedure time with the radial approach.
This meta-analysis is the most comprehensive in evalu-
ating safety and efﬁcacy endpoints and the ﬁrst to include
data from the RIFLE-STEACS (Radial Versus Femoral
Randomized Investigation in ST-Segment Elevation Acuteersus femoral access approach on risk of access site bleeding in STEMI patients
Figure 6. Stroke
Meta-analysis of pooled data from randomized studies showing the effect of radial versus femoral access approach on risk of stroke in STEMI patients treated with
primary PCI. Abbreviations as in Table 1 and Figure 2.
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820Coronary Syndrome) (11) and STEMI-RADIAL (A Pro-
spective Randomized Trial of Radial vs. Femoral Access in
Patients With ST-Segment Elevation Myocardial Infarc-
tion) studies (13). The RIVAL (Radial Vs. Femoral Access
for Coronary Intervention) and RIFLE-STEACS studies
contributed most of the data analyzed. However, major
bleeding was not signiﬁcantly different between the study
arms in either of these trials, which is likely due to having
insufﬁcient power to demonstrate a difference. On the
contrary, by combining all the randomized evidence, we
were able to demonstrate a signiﬁcant decrease in major
bleeding using the radial approach. Overall, our results areFigure 7. Recurrent MI
Meta-analysis of pooled data from randomized studies showing the effect of radial ve
patients treated with primary PCI. MI ¼ myocardial infarction; other abbreviations arobust, given the lack of heterogeneity within studies for all
of our included endpoints. Two previous meta-analyses have
been conducted to study the best access approach in acute
MI patients. The ﬁrst included both randomized and
observational studies (84% of the studied population) and
thus was likely affected by confounding and selection bias
(24). A recently published meta-analysis limited only to
randomized controlled trials, but did not include data from
RIFLE-STEACS or STEMI-RADIAL, demonstrated
a decrease in mortality with a nonsigniﬁcant trend of
decrease in major bleeding (25). This again is likely
secondary to insufﬁcient number of populations studied.rsus femoral access approach on risk of recurrent myocardial infarction in STEMI
s in Table 1 and Figure 2.
Figure 8. TLR/TVR
Meta-analysis of pooled data from randomized studies showing the effect of radial versus femoral access approach on risk of TLR/TVR in STEMI patients treated with
primary PCI. TLR ¼ target lesion revascularization; TVR ¼ target vessel revascularization; other abbreviations as in Table 1 and Figure 2.
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821Since its introduction in 1989, the radial route has gained
increased popularity especially with the evolving technology
and increasing experience of interventional cardiologists (26).
The radial artery’s superﬁcial course permits early recognition
of bleeding at access sites and allows easy compressibility.
Thus, hemostasis can be achieved safely and rapidly. In
addition, there are no adjacent structures susceptible to be
damaged during percutaneous procedures and thus access site
complications are expected to decrease with the radial
approach in comparison with the femoral approach. The
limitation of the smaller caliber of the radial artery is over-
come with the evolving technology and even the advanced
equipment that are potentially useful in current PCI practice
(such as distal embolic protection devices, aspiration cathe-
ters, bifurcation balloons and stents, and intravascular
imaging probes) are compatible with 6-F access sheathes.Figure 9. Overall Procedure Time
Meta-analysis of pooled data from randomized studies showing the effect of radial ver
with primary PCI. Abbreviations as in Table 1 and Figure 2.The improved survival associated with the radial approach
observed in our analysis is consistent with recent data
demonstrating that implementing peri-PCI bleeding
avoidance strategies leads to reduction in mortality (6). Both
access- and non-access-site bleeding have been indepen-
dently associated with increased short-term and long-term
mortality (9). STEMI patients treated with primary PCI are
particularly likely to beneﬁt from the bleed reduction of the
radial approach as these patients have a greater risk of access
site bleeding and other access-related complications given
the emergent nature of the procedure and the need for
aggressive antiplatelet and antithrombotic therapies (12).
Another potential beneﬁt of the radial approach is that it
may allow higher doses of anticoagulants to be used for
further ischemic reduction while minimizing the penalty of
increased bleeding (8).sus femoral access approach on overall procedure time in STEMI patients treated
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822The overwhelming results favoring the radial approach
notwithstanding, its acceptance as a preferred route of access
in primary PCI might be met by several challenges. The
greater anatomic variability of the course and distribution of
the radial artery in the arm as well as challenges in cannu-
lating the coronary arteries via radial access may increase
procedural time and account for a higher rate of crossover to
the femoral route. This may be detrimental in STEMI
patients, where timely reperfusion is critical. We found that
procedure time with the radial approach was longer by only
1.5 min, suggesting that procedural delay may not be
a signiﬁcant concern when performed by experienced oper-
ators. Conversely, the femoral approach allows for the
convenient acquisition of central venous access and insertion
of hemodynamic assist devices in unstable patients. Patients
with cardiogenic shock were excluded from most of the trials
except RIFLE-STEACS, where an intra-aortic balloon
pump was used 8.4% and 7.6% in the femoral and the radial
approaches, respectively (p ¼ 0.73) (11). However, it
remains unknown whether the radial approach would
remain efﬁcacious in unstable patients and patients with
cardiogenic shock. Finally, in a recent study of 51 patients
randomized to the radial approach versus the femoral
approach during diagnostic coronary angiography, the radial
approach generated signiﬁcantly more particulate cerebral
microemboli (27). In the current study, we found no
difference in clinically evident strokes between the 2
approaches.
Study limitations. The low rate of crossover and difference
in procedure time in the included studies reﬂects the
adequate experience of operators with both techniques and
raises a concern of generalizability of our ﬁndings. Most of
the included studies are either single-center or include only
a few centers with high concentrations of experienced radial
operators. Degree of operator experience is important,
especially given that a learning curve for radial artery
intervention has been clearly demonstrated (28). Another
limitation of our study is the substantial heterogeneity
among the bleeding deﬁnitions used in the included studies.
The newly proposed consensus classiﬁcation for bleeding
may help overcome such a limitation in the future (29).
Finally, 4 studies (11,12,16,17) included in our analysis
were not strictly limited to primary PCI and included
patients with rescue PCI. However, these patients were
equally distributed in the both treatment arms and were
unlikely to affect the major ﬁndings of the current study
(Table 1).Conclusions
Our ﬁndings support the use of the radial artery over the
femoral artery in primary PCI to optimize outcomes in
STEMI patients. Radial access for STEMI by experiencedoperators is associated with decreased bleeding and
improved survival.Reprint requests and correspondence: Dr. Wassef Karrowni,
University of Iowa Hospitals and Clinics, Division of Cardiovas-
cular Diseases, 200 Hawkins Drive, Int. Med. E316-1 GH, Iowa
City, Iowa 52242. E-mail: wassef@hotmail.com.REFERENCES
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